APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Penicillin and Streptomycin

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Penicillin and Streptomycin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174023340322 December 2025190 pages

Choose your research edition.

Industry ResearchPenicillin and Streptomycin Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Penicillin and Streptomycin Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Penicillin and Streptomycin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Penicillin and Streptomycin Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Penicillin and Streptomycin Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Penicillin and Streptomycin market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Penicillin and Streptomycin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Penicillin and Streptomycin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Penicillin and Streptomycin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Penicillin and Streptomycin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Penicillin and Streptomycin include Takeda Pharmaceutical, Johnson & Johnson, Merck, Eli Lilly, GlaxoSmithKline, Toyama Chemical, MiddleBrook Pharmaceuticals, Gilead Sciences and Astra Zeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Penicillin and Streptomycin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Penicillin and Streptomycin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Penicillin and Streptomycin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Penicillin and Streptomycin market size, projected growth trends, production technologies, key applications, and end-use industries.

Penicillin and Streptomycin Segment by Company

Takeda Pharmaceutical

Johnson & Johnson

Merck

Eli Lilly

GlaxoSmithKline

Toyama Chemical

MiddleBrook Pharmaceuticals

Gilead Sciences

Astra Zeneca

Astellas Pharma

Penicillin and Streptomycin Segment by Type

Penicillin

Streptomycin

Penicillin and Streptomycin Segment by Application

Throat Infections

Meningitis

Tuberculosis Treatment

Penicillin and Streptomycin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Penicillin and Streptomycin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Penicillin and Streptomycin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Penicillin and Streptomycin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Penicillin and Streptomycin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Penicillin and Streptomycin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Penicillin and Streptomycin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Penicillin and Streptomycin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Penicillin and Streptomycin Industry Trends Table 2. Penicillin and Streptomycin Industry Drivers Table 3. Penicillin and Streptomycin Industry Opportunities and Challenges Table 4. Penicillin and Streptomycin Industry Restraints Table 5. Global Penicillin and Streptomycin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Penicillin and Streptomycin Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Penicillin and Streptomycin Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Penicillin and Streptomycin Sales Market Share by Manufacturers Table 9. Global Penicillin and Streptomycin Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Penicillin and Streptomycin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Penicillin and Streptomycin Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Penicillin and Streptomycin Manufacturers, Product Type & Application Table 13. Global Penicillin and Streptomycin Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Penicillin and Streptomycin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Penicillin Table 17. Major Manufacturers of Streptomycin Table 18. Global Penicillin and Streptomycin Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Penicillin and Streptomycin Sales by Type (2021-2026) & (k units) Table 20. Global Penicillin and Streptomycin Sales by Type (2027-2032) & (k units) Table 21. Global Penicillin and Streptomycin Sales Market Share by Type (2021-2026) Table 22. Global Penicillin and Streptomycin Sales Market Share by Type (2027-2032) Table 23. Global Penicillin and Streptomycin Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Penicillin and Streptomycin Revenue by Type (2021-2026) & (k units) Table 25. Global Penicillin and Streptomycin Revenue by Type (2027-2032) & (k units) Table 26. Global Penicillin and Streptomycin Revenue Market Share by Type (2021-2026) Table 27. Global Penicillin and Streptomycin Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Throat Infections Table 29. Major Manufacturers of Meningitis Table 30. Major Manufacturers of Tuberculosis Treatment Table 31. Global Penicillin and Streptomycin Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Penicillin and Streptomycin Sales by Application (2021-2026) & (k units) Table 33. Global Penicillin and Streptomycin Sales by Application (2027-2032) & (k units) Table 34. Global Penicillin and Streptomycin Sales Market Share by Application (2021-2026) Table 35. Global Penicillin and Streptomycin Sales Market Share by Application (2027-2032) Table 36. Global Penicillin and Streptomycin Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Penicillin and Streptomycin Revenue by Application (2021-2026) & (k units) Table 38. Global Penicillin and Streptomycin Revenue by Application (2027-2032) & (k units) Table 39. Global Penicillin and Streptomycin Revenue Market Share by Application (2021-2026) Table 40. Global Penicillin and Streptomycin Revenue Market Share by Application (2027-2032) Table 41. Global Penicillin and Streptomycin Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Penicillin and Streptomycin Sales by Region (2021-2026) & (k units) Table 43. Global Penicillin and Streptomycin Sales Market Share by Region (2021-2026) Table 44. Global Penicillin and Streptomycin Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Penicillin and Streptomycin Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Penicillin and Streptomycin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Penicillin and Streptomycin Sales by Country (2021-2026) & (k units) Table 48. North America Penicillin and Streptomycin Sales by Country (2027-2032) & (k units) Table 49. Europe Penicillin and Streptomycin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Penicillin and Streptomycin Sales by Country (2021-2026) & (k units) Table 51. Europe Penicillin and Streptomycin Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Penicillin and Streptomycin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Penicillin and Streptomycin Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Penicillin and Streptomycin Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Penicillin and Streptomycin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Penicillin and Streptomycin Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Penicillin and Streptomycin Sales by Country (2027-2032) & (k units) Table 58. Global Penicillin and Streptomycin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Penicillin and Streptomycin Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Penicillin and Streptomycin Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Penicillin and Streptomycin Revenue Market Share by Region (2021-2026) Table 62. Global Penicillin and Streptomycin Revenue Market Share by Region (2027-2032) Table 63. Takeda Pharmaceutical Company Information Table 64. Takeda Pharmaceutical Business Overview Table 65. Takeda Pharmaceutical Penicillin and Streptomycin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Takeda Pharmaceutical Penicillin and Streptomycin Product Portfolio Table 67. Takeda Pharmaceutical Recent Development Table 68. Johnson & Johnson Company Information Table 69. Johnson & Johnson Business Overview Table 70. Johnson & Johnson Penicillin and Streptomycin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Johnson & Johnson Penicillin and Streptomycin Product Portfolio Table 72. Johnson & Johnson Recent Development Table 73. Merck Company Information Table 74. Merck Business Overview Table 75. Merck Penicillin and Streptomycin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Merck Penicillin and Streptomycin Product Portfolio Table 77. Merck Recent Development Table 78. Eli Lilly Company Information Table 79. Eli Lilly Business Overview Table 80. Eli Lilly Penicillin and Streptomycin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Eli Lilly Penicillin and Streptomycin Product Portfolio Table 82. Eli Lilly Recent Development Table 83. GlaxoSmithKline Company Information Table 84. GlaxoSmithKline Business Overview Table 85. GlaxoSmithKline Penicillin and Streptomycin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. GlaxoSmithKline Penicillin and Streptomycin Product Portfolio Table 87. GlaxoSmithKline Recent Development Table 88. Toyama Chemical Company Information Table 89. Toyama Chemical Business Overview Table 90. Toyama Chemical Penicillin and Streptomycin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Toyama Chemical Penicillin and Streptomycin Product Portfolio Table 92. Toyama Chemical Recent Development Table 93. MiddleBrook Pharmaceuticals Company Information Table 94. MiddleBrook Pharmaceuticals Business Overview Table 95. MiddleBrook Pharmaceuticals Penicillin and Streptomycin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. MiddleBrook Pharmaceuticals Penicillin and Streptomycin Product Portfolio Table 97. MiddleBrook Pharmaceuticals Recent Development Table 98. Gilead Sciences Company Information Table 99. Gilead Sciences Business Overview Table 100. Gilead Sciences Penicillin and Streptomycin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Gilead Sciences Penicillin and Streptomycin Product Portfolio Table 102. Gilead Sciences Recent Development Table 103. Astra Zeneca Company Information Table 104. Astra Zeneca Business Overview Table 105. Astra Zeneca Penicillin and Streptomycin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Astra Zeneca Penicillin and Streptomycin Product Portfolio Table 107. Astra Zeneca Recent Development Table 108. Astellas Pharma Company Information Table 109. Astellas Pharma Business Overview Table 110. Astellas Pharma Penicillin and Streptomycin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Astellas Pharma Penicillin and Streptomycin Product Portfolio Table 112. Astellas Pharma Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Penicillin and Streptomycin Distributors List Table 116. Penicillin and Streptomycin Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Penicillin and Streptomycin Product Image Figure 2. Global Penicillin and Streptomycin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Penicillin and Streptomycin Market Size (2021-2032) & (US$ Million) Figure 4. Global Penicillin and Streptomycin Sales (2021-2032) & (k units) Figure 5. Global Penicillin and Streptomycin Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Penicillin and Streptomycin Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Penicillin Image Figure 9. Streptomycin Image Figure 10. Global Penicillin and Streptomycin Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Penicillin and Streptomycin Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Penicillin and Streptomycin Sales Market Share by Type (2021-2032) Figure 13. Global Penicillin and Streptomycin Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Penicillin and Streptomycin Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Penicillin and Streptomycin Revenue Market Share by Type (2021-2032) Figure 16. Throat Infections Image Figure 17. Meningitis Image Figure 18. Tuberculosis Treatment Image Figure 19. Global Penicillin and Streptomycin Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Penicillin and Streptomycin Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Penicillin and Streptomycin Sales Market Share by Application (2021-2032) Figure 22. Global Penicillin and Streptomycin Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Penicillin and Streptomycin Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Penicillin and Streptomycin Revenue Market Share by Application (2021-2032) Figure 25. North America Penicillin and Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Penicillin and Streptomycin Sales Market Share by Country (2021-2032) Figure 27. U.S. Penicillin and Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Penicillin and Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Penicillin and Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Penicillin and Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Penicillin and Streptomycin Sales Market Share by Country (2021-2032) Figure 32. Germany Penicillin and Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Penicillin and Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Penicillin and Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Penicillin and Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Penicillin and Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Penicillin and Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Penicillin and Streptomycin Sales Market Share by Country (2021-2032) Figure 39. China Penicillin and Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Penicillin and Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Penicillin and Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Penicillin and Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Penicillin and Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Penicillin and Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Penicillin and Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Penicillin and Streptomycin Sales Market Share by Country (2021-2032) Figure 47. Brazil Penicillin and Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Penicillin and Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Penicillin and Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Penicillin and Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Penicillin and Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Penicillin and Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Penicillin and Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Penicillin and Streptomycin Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Penicillin and Streptomycin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Penicillin and Streptomycin Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Penicillin and Streptomycin Revenue (2021-2032) & (US$ Million) Figure 58. North America Penicillin and Streptomycin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Penicillin and Streptomycin Revenue (2021-2032) & (US$ Million) Figure 60. Europe Penicillin and Streptomycin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Penicillin and Streptomycin Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Penicillin and Streptomycin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Penicillin and Streptomycin Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Penicillin and Streptomycin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Penicillin and Streptomycin Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Penicillin and Streptomycin Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Penicillin
  • Streptomycin
Applications
  • Throat Infections
  • Meningitis
  • Tuberculosis Treatment
Companies covered
  • Takeda Pharmaceutical
  • Johnson & Johnson
  • Merck
  • Eli Lilly
  • GlaxoSmithKline
  • Toyama Chemical
  • MiddleBrook Pharmaceuticals
  • Gilead Sciences
  • Astra Zeneca
  • Astellas Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Penicillin and Streptomycin Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Penicillin and Streptomycin Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Penicillin and Streptomycin Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Penicillin and Streptomycin Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Penicillin and Streptomycin Market Dynamics
  1. 2.1 Penicillin and Streptomycin Industry Trends
  2. 2.2 Penicillin and Streptomycin Industry Drivers
  3. 2.3 Penicillin and Streptomycin Industry Opportunities and Challenges
  4. 2.4 Penicillin and Streptomycin Industry Restraints
3 Penicillin and Streptomycin Market by Manufacturers
  1. 3.1 Global Penicillin and Streptomycin Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Penicillin and Streptomycin Sales by Manufacturers (2021-2026)
  3. 3.3 Global Penicillin and Streptomycin Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Penicillin and Streptomycin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Penicillin and Streptomycin Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Penicillin and Streptomycin Manufacturers, Product Type & Application
  7. 3.7 Global Penicillin and Streptomycin Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Penicillin and Streptomycin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Penicillin and Streptomycin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Penicillin and Streptomycin Tier 1, Tier 2, and Tier 3
4 Penicillin and Streptomycin Market by Type
  1. 4.1 Penicillin and Streptomycin Type Introduction
  2. 4.1.1 Penicillin
  3. 4.1.2 Streptomycin
  4. 4.2 Global Penicillin and Streptomycin Sales by Type
  5. 4.2.1 Global Penicillin and Streptomycin Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Penicillin and Streptomycin Sales by Type (2021-2032)
  7. 4.2.3 Global Penicillin and Streptomycin Sales Market Share by Type (2021-2032)
  8. 4.3 Global Penicillin and Streptomycin Revenue by Type
  9. 4.3.1 Global Penicillin and Streptomycin Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Penicillin and Streptomycin Revenue by Type (2021-2032)
  11. 4.3.3 Global Penicillin and Streptomycin Revenue Market Share by Type (2021-2032)
5 Penicillin and Streptomycin Market by Application
  1. 5.1 Penicillin and Streptomycin Application Introduction
  2. 5.1.1 Throat Infections
  3. 5.1.2 Meningitis
  4. 5.1.3 Tuberculosis Treatment
  5. 5.2 Global Penicillin and Streptomycin Sales by Application
  6. 5.2.1 Global Penicillin and Streptomycin Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Penicillin and Streptomycin Sales by Application (2021-2032)
  8. 5.2.3 Global Penicillin and Streptomycin Sales Market Share by Application (2021-2032)
  9. 5.3 Global Penicillin and Streptomycin Revenue by Application
  10. 5.3.1 Global Penicillin and Streptomycin Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Penicillin and Streptomycin Revenue by Application (2021-2032)
  12. 5.3.3 Global Penicillin and Streptomycin Revenue Market Share by Application (2021-2032)
6 Global Penicillin and Streptomycin Sales by Region
  1. 6.1 Global Penicillin and Streptomycin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Penicillin and Streptomycin Sales by Region (2021-2032)
  3. 6.2.1 Global Penicillin and Streptomycin Sales by Region (2021-2026)
  4. 6.2.2 Global Penicillin and Streptomycin Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Penicillin and Streptomycin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Penicillin and Streptomycin Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Penicillin and Streptomycin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Penicillin and Streptomycin Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Penicillin and Streptomycin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Penicillin and Streptomycin Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Penicillin and Streptomycin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Penicillin and Streptomycin Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Penicillin and Streptomycin Revenue by Region
  1. 7.1 Global Penicillin and Streptomycin Revenue by Region
  2. 7.1.1 Global Penicillin and Streptomycin Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Penicillin and Streptomycin Revenue by Region (2021-2026)
  4. 7.1.3 Global Penicillin and Streptomycin Revenue by Region (2027-2032)
  5. 7.1.4 Global Penicillin and Streptomycin Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Penicillin and Streptomycin Revenue (2021-2032)
  8. 7.2.2 North America Penicillin and Streptomycin Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Penicillin and Streptomycin Revenue (2021-2032)
  11. 7.3.2 Europe Penicillin and Streptomycin Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Penicillin and Streptomycin Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Penicillin and Streptomycin Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Penicillin and Streptomycin Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Penicillin and Streptomycin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda Pharmaceutical
  2. 8.1.1 Takeda Pharmaceutical Company Information
  3. 8.1.2 Takeda Pharmaceutical Business Overview
  4. 8.1.3 Takeda Pharmaceutical Penicillin and Streptomycin Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Pharmaceutical Penicillin and Streptomycin Product Portfolio
  6. 8.1.5 Takeda Pharmaceutical Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Penicillin and Streptomycin Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Penicillin and Streptomycin Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Penicillin and Streptomycin Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck Penicillin and Streptomycin Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 Eli Lilly
  20. 8.4.1 Eli Lilly Company Information
  21. 8.4.2 Eli Lilly Business Overview
  22. 8.4.3 Eli Lilly Penicillin and Streptomycin Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Eli Lilly Penicillin and Streptomycin Product Portfolio
  24. 8.4.5 Eli Lilly Recent Developments
  25. 8.5 GlaxoSmithKline
  26. 8.5.1 GlaxoSmithKline Company Information
  27. 8.5.2 GlaxoSmithKline Business Overview
  28. 8.5.3 GlaxoSmithKline Penicillin and Streptomycin Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 GlaxoSmithKline Penicillin and Streptomycin Product Portfolio
  30. 8.5.5 GlaxoSmithKline Recent Developments
  31. 8.6 Toyama Chemical
  32. 8.6.1 Toyama Chemical Company Information
  33. 8.6.2 Toyama Chemical Business Overview
  34. 8.6.3 Toyama Chemical Penicillin and Streptomycin Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Toyama Chemical Penicillin and Streptomycin Product Portfolio
  36. 8.6.5 Toyama Chemical Recent Developments
  37. 8.7 MiddleBrook Pharmaceuticals
  38. 8.7.1 MiddleBrook Pharmaceuticals Company Information
  39. 8.7.2 MiddleBrook Pharmaceuticals Business Overview
  40. 8.7.3 MiddleBrook Pharmaceuticals Penicillin and Streptomycin Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 MiddleBrook Pharmaceuticals Penicillin and Streptomycin Product Portfolio
  42. 8.7.5 MiddleBrook Pharmaceuticals Recent Developments
  43. 8.8 Gilead Sciences
  44. 8.8.1 Gilead Sciences Company Information
  45. 8.8.2 Gilead Sciences Business Overview
  46. 8.8.3 Gilead Sciences Penicillin and Streptomycin Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Gilead Sciences Penicillin and Streptomycin Product Portfolio
  48. 8.8.5 Gilead Sciences Recent Developments
  49. 8.9 Astra Zeneca
  50. 8.9.1 Astra Zeneca Company Information
  51. 8.9.2 Astra Zeneca Business Overview
  52. 8.9.3 Astra Zeneca Penicillin and Streptomycin Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Astra Zeneca Penicillin and Streptomycin Product Portfolio
  54. 8.9.5 Astra Zeneca Recent Developments
  55. 8.10 Astellas Pharma
  56. 8.10.1 Astellas Pharma Company Information
  57. 8.10.2 Astellas Pharma Business Overview
  58. 8.10.3 Astellas Pharma Penicillin and Streptomycin Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Astellas Pharma Penicillin and Streptomycin Product Portfolio
  60. 8.10.5 Astellas Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Penicillin and Streptomycin Value Chain Analysis
  2. 9.1.1 Penicillin and Streptomycin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Penicillin and Streptomycin Production Mode & Process
  6. 9.2 Penicillin and Streptomycin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Penicillin and Streptomycin Distributors
  9. 9.2.3 Penicillin and Streptomycin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst